share_log

Mateon Therapeutics Inc | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Mateon Therapeutics Inc | SC 13D:超过5%持股股东披露文件

美股SEC公告 ·  2019/05/02 17:27
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息